Abdulrahman Nasiri: Alloimmune Thrombocytopenia After Liver Transplantation from Donor with ITP
Abdulrahman Nasiri, Assistant Professor of Medicine and Hematology at Imam Mohammad Ibn Saud Islamic University, shared on LinkedIn:
”I am pleased to share the publication of our recent case report in Hematology:
“Transplantation-mediated alloimmune thrombocytopenia following liver transplantation from a donor with ITP: a case report and review of the literature.”
This report describes a rare but serious complication of liver transplantation, where donor derived immune cells caused profound thrombocytopenia in the recipient.
Our case highlights that intensive medical therapy alone can achieve full recovery and avoid the need for retransplantation, an important insight for transplant teams worldwide.
I am deeply grateful to my colleagues for their dedication and to Dr. Hazzaa Alzahrani for his invaluable guidance and supervision throughout this work.”
Read the full article here.
Article: Transplantation-mediated alloimmune thrombocytopenia following liver transplantation from a donor with ITP: a case report and review of the literature
Authors: Ahmed Bin Salman, Mostafa F. Mohammed Saleh, Abdulrahman Nasiri, Hazza Alzahran
Stay informed on the latest scientific advances in the field of platelet disorders with Hemostasis Today.
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show